NCT02295202

Impact of Obstructive Sleep Apnea Treatment in Patients With Metabolic Syndrome

Impact of Obstructive Sleep Apnea Treatment in Patients With Metabolic Syndrome: A Randomized Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: University of Sao Paulo · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Obstructive Sleep Apnea (OSA) is a common condition that may induce hemodynamic and metabolic dysregulation. However, it is not clear if OSA is a mere epiphenomenon or contributes to increase the morbidity associated with metabolic syndrome. This study was designed to evaluate the impact of OSA treatment with CPAP in consecutive patients with metabolic syndrome.

Conditions

• Sleep Apnea
• Metabolic Syndrome

Interventions

Type	Name	Description
DEVICE	CPAP (REMstar System One Plus - Philips Medical Systems)	Standard device for treating obstructive sleep apnea.
DEVICE	Nasal strips

Timeline

• Start date: 2015-03-01
• Primary completion: 2019-04-01
• Completion: 2019-12-01
• First posted: 2014-11-20
• Last updated: 2020-06-18

Locations

1 site across 1 country: Brazil